Delcath Systems Inc. (NASDAQ:DCTH) shares dropped 7.8% during trading on Friday . The company traded as low as $4.21 and last traded at $4.25, with a volume of 70,730 shares changing hands. The stock had previously closed at $4.61.

The company’s 50-day moving average price is $4.00 and its 200-day moving average price is $4.63. The company’s market cap is $6.40 million.

Delcath Systems (NASDAQ:DCTH) last released its earnings results on Wednesday, May 4th. The medical device company reported ($0.08) EPS for the quarter, beating analysts’ consensus estimates of ($0.19) by $0.11. Equities analysts forecast that Delcath Systems Inc. will post ($7.84) EPS for the current fiscal year.

Delcath Systems, Inc is a late-stage clinical development company with early commercial activity in Europe focused on cancers of the liver. The Company is a specialty pharmaceutical and medical device company developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.